A Case Report on Systemic Lupus Erythematosus in a 21 Year Old Indian Female
Asian Journal of Case Reports in Medicine and Health, Volume 6, Issue 1,
Page 24-28
Abstract
Background: SLE is a systemic auto-immune disease that mostly affects females and has a wide range of clinical symptoms and immunological abnormalities. Lupus may have an impact on almost any organ, but the kidney and central nervous system are the most noticeable and destructive. Each patient's level of severity can vary, resulting in anything from little organ damage to significant cutaneous involvement and a long-lasting remission to death. Additionally, the severity of the condition can vary widely, with the majority of patients experiencing flare-ups followed by protracted remissions.
Case Presentation: A 21-year-old female patient was brought to the female medicine department with the primary symptoms of face rashes, hair loss, abdominal pain dating back eight months, and joint pain spanning two to three years. The patient was diagnosed with SLE based on his medical history, physical examination, and laboratory tests. Her vital signs were continuously watched during her 14-day hospital stay, and several laboratory tests were run to rule out any organ or organ system damage. Her primary drugs were NSAIDs, antimalarials, and corticosteroids.
Conclusion: It has been determined that the patient has been afflicted with the disease for the last two years based on investigative reports and patient history. She was unable to have a timely medical examination due to her precarious financial situation, which caused a delay in her treatment. Due to the fact that this ailment can only be controlled and not fully healed, the patient needs therapy and counselling.
- Systemic lupus erythematosus
- NSAIDs
- immunosuppressants
- corticosteroids
How to Cite
References
Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020;172(11):ITC81–96. Available:http://dx.doi.org/10.7326/aitc202006020
Fortuna G, Brennan MT. Systemic lupus erythematosus: Epidemiology, pathophysiology, manifestations, and management. Dent Clin North Am. 2013;57(4):631–55. DOI: 10.1016/j.cden.2013.06.003
Wells BG, DiPiro JT, Schwinghammer TL, Di Piro CV. Pharmacotherapy handbook, Tenth Edition. 10th ed. Columbus, OH, USA: McGraw-Hill Education; 2017.
Luo F, Ye Q, Shen J. Systemic lupus erythematosus with trisomy X: A case report and review of the literature. Journal of Medical Case Reports. 2022;16(1):281. Available:https://doi.org/10.1186/s13256-022-03478-5
Nifras M, Hameed S, Manotharan S, De Alwis T, Iqbal M. Systemic lupus erythematosus: A case report; 2017.
Available:https://doi.org/10.13140/RG.2.2.10551.83364
Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365 (22):2110–21.
Available:https://pubmed.ncbi.nlm.nih.gov/22129255/ DOI: 10.1056/NEJMra1100359 Access on 2022 Oct 27
Malaviya AN, Singh RR, Singh YN, Kapoor SK, Kumar A. Prevalence of systemic lupus erythematosus in India. Lupus. 1993; 2(2):115–8. Available:https://pubmed.ncbi.nlm.nih.gov/8330032/DOI: 10.1177/096120339300200209
Access on 2022 Oct 27
Case report on systemic lupus erythematosus. Indian Journal of Forensic Medicine and Toxicology; 2020.
Available:https://doi.org/10.37506/ijfmt.v14i4.12650
Schrezenmeier E, Dörner T. Mechanisms of action of hydroxychloroquine and chloroquine: Implications for rheumatology. Nat Rev Rheumatol. 2020;16(3):155-166. DOI: 10.1038/s41584-020-0372-x Epub 2020 Feb 7
Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56(7):481–90.
Available:https://jcp.bmj.com/content/jclinpath/56/7/481.full.pdf DOI: 10.1136/jcp.56.7.481
Aringer M, Schneider M. Systemic lupus erythematosus. Dtsch Med Wochenschr; 2016;141(8):537–43.
Available:https://pubmed.ncbi.nlm.nih.gov/27022764 DOI: 10.1007/s00105-021-04794-5 Access on 2022 Oct 27
-
Abstract View: 54 times
PDF Download: 6 times
